Financial Contrast: Growlife (PHOT) versus The Competition

Risk and Volatility

Growlife has a beta of 2.3, meaning that its share price is 130% more volatile than the S&P 500. Comparatively, Growlife’s rivals have a beta of 1.22, meaning that their average share price is 22% more volatile than the S&P 500.

Profitability

This table compares Growlife and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Growlife	N/A	N/A	N/A
Growlife Competitors	-12.19%	-0.93%	-1.00%

Valuation & Earnings

This table compares Growlife and its rivals revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Growlife	N/A	-$4.48 million	0.00
Growlife Competitors	$2.84 billion	$79.78 million	-3.57

Growlife’s rivals have higher revenue and earnings than Growlife. Growlife is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Insider and Institutional Ownership

40.3% of shares of all “CONSM PD – MISC DIS” companies are owned by institutional investors. 2.8% of Growlife shares are owned by insiders. Comparatively, 21.6% of shares of all “CONSM PD – MISC DIS” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Growlife beats its rivals on 5 of the 9 factors compared.

About Growlife

GrowLife, Inc. focuses on the functional mushroom business. It processes, stores, markets, distributes, and sells fresh and dried mushroom products. The company was founded in 2012 and is headquartered in Kirkland, Washington.